NCT05411757 2022-06-09
IBR900 Cell Injection Combined With Lenvatinib or Bevacizumab in the Treatment of Advanced Primary Liver Cancer
Shandong Public Health Clinical Center
Phase EARLY_PHASE1 Unknown
Shandong Public Health Clinical Center
BeiJing Yijiayi Medicine Techonoloy Co., Ltd.
BeiJing Yijiayi Medicine Techonoloy Co., Ltd.